NKTR•benzinga•
Nektar Therapeutics Q4 2024 Adj. EPS $(0.15) Beats $(0.17) Estimate, Sales $29.200M Miss $29.860M Estimate
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 12, 2025 by benzinga